Jetking Infotrain Limited (BOM:517063)

Marinus Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	17.04	24.58	75.13	33.65	27
Short-Term Investments	-	-	10.87	31.56	14.74	5.74
Cash & Short-Term Investments	17.04	17.04	35.45	106.69	48.39	32.74
Cash Growth	-52.21%	-51.92%	-66.78%	120.47%	47.82%	165.96%
Accounts Receivable	-	21.13	13.24	22.17	22.34	24.61
Other Receivables	-	-	0.06	0.8	0.27	0.07
Receivables	-	21.13	13.3	25.09	22.61	24.68
Inventory	-	-	1.35	1.28	2.19	2.46
Prepaid Expenses	-	-	1.92	1.72	0.87	0.8
Other Current Assets	-	17.27	9.82	10.44	8.08	6.57
Total Current Assets	-	55.44	61.84	145.22	82.15	67.24
Property, Plant & Equipment	-	208.05	202.57	148.99	83.51	85.55
Long-Term Investments	-	26.56	78.18	51.28	92.3	85.09
Other Intangible Assets	-	116.21	3.3	4.56	6.42	7.4
Other Long-Term Assets	-	108.81	117.21	113.48	176.11	176.22
Total Assets	-	515.07	463.1	463.52	440.48	421.5
Accounts Payable	-	16.08	13.25	10.75	7.56	10.21
Accrued Expenses	-	2.17	21.78	18.66	14.05	13.51
Current Portion of Long-Term Debt	-	0.18	-	-	-	-
Current Portion of Leases	-	3.84	3.54	4.61	4.38	1.51
Current Unearned Revenue	-	-	11.23	10.05	4.42	3.5
Other Current Liabilities	-	33.07	1.5	1.61	4.29	3.11
Total Current Liabilities	-	55.35	51.3	45.68	34.7	31.83
Long-Term Debt	-	4.81	-	-	-	-
Long-Term Leases	-	11.07	11.34	11.95	5.06	2.88
Long-Term Unearned Revenue	-	-	1.15	1.33	1.57	1.76
Long-Term Deferred Tax Liabilities	-	10.79	-	-	-	2.48
Other Long-Term Liabilities	-	6.21	3.7	3.97	6.4	7.05
Total Liabilities	-	93.98	73.64	66.48	48.03	46
Common Stock	-	59.08	59.08	59.08	59.08	59.08
Additional Paid-In Capital	-	-	0.94	0.94	0.94	0.94
Retained Earnings	-	-	328.34	333.36	325.88	308.52
Comprehensive Income & Other	-	362.01	1.09	3.67	6.55	6.97
Shareholders' Equity	421.09	421.09	389.45	397.05	392.45	375.5
Total Liabilities & Equity	-	515.07	463.1	463.52	440.48	421.5
Total Debt	19.9	19.9	14.87	16.56	9.44	4.39
Net Cash (Debt)	-2.86	-2.86	20.57	90.13	38.95	28.35
Net Cash Growth	-	-	-77.17%	131.39%	37.40%	384.09%
Net Cash Per Share	-0.48	-0.48	3.48	15.26	6.59	4.80
Filing Date Shares Outstanding	6.08	5.9	5.91	5.91	5.91	5.91
Total Common Shares Outstanding	6.08	5.9	5.91	5.91	5.91	5.91
Working Capital	-	0.1	10.54	99.53	47.45	35.41
Book Value Per Share	71.34	71.34	65.92	67.21	66.43	63.56
Tangible Book Value	304.88	304.88	386.15	392.49	386.03	368.1
Tangible Book Value Per Share	51.66	51.66	65.37	66.44	65.35	62.31
Buildings	-	-	182.35	129.52	71.82	72.92
Machinery	-	-	149.08	128.65	111.63	130.03
Leasehold Improvements	-	-	8.47	11.77	6.18	8.02

Source: S&P Global Market Intelligence. Standard template. Financial Sources.